Indeed, to better define the relevance of adenosine signaling in lung cancer, an interesting relationship between immunohistochemistry (IHC) expression of CD73 in tumor tissues and clinical outcome has been found in patients with advanced NSCLC (stage I-III) (76). The gene discussed is NT5E; the disease is lung carcinoma.